Biotechnology - Politics, Pharmaceutical

Filter

Current filters:

PoliticsPharmaceutical

Popular Filters

1 to 25 of 35 results

Leaked Commission research documents raise questions about whose interests are being prioritized

08-10-2013

Scientists, public health researchers and non-governmental organizations have reacted with concern to…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsResearch

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

HAI Europe questions pharma commitment to clinical trial data transparency, claiming leaked documents suggest otherwise

29-07-2013

Consumer advocacy Health Action International (HAI) Europe says it welcomes any initiative that grants…

BiotechnologyEuropeNorth AmericaPharmaceuticalPoliticsRegulationResearch

Bipartisan Bill exempting FDA user fees from sequestration introduced in USA

22-07-2013

A bipartisan group of US House of Representatives Members last week introduced the FDA Safety Over Sequestration…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPolitics

Government programs play huge role in growth of Turkey's health care market; F&S report

04-06-2013

Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases…

BiotechnologyEuropeHealthcareMarkets & MarketingPharmaceuticalPolitics

MoCA report a welcome stepping stone, but access to orphan medicines remains unfinished business, say trade groups

09-05-2013

The three leading pharma/biotech trade bodies, EuropaBio, the European Federation of Pharmaceutical Industries…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsRare diseasesRegulation

President Obama's 2014 budget proposal a mixed bag for pharma

11-04-2013

US President Barack Obama $3.77 trillion budget proposal for fiscal 2014 delivers mixed news for the…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalPolitics

UK govt launches review of business-university growth opportunities, to be led by GlaxoSmithKline CEO

10-04-2013

A review to boost growth opportunities for universities and businesses in the UK has been launched by…

BiotechnologyEuropeGlaxoSmithKlinePharmaceuticalPoliticsResearch

Number of new clinical trials in Australia continues to fall

08-04-2013

New figures from Australia's Therapeutic Goods Administration show that the number of clinical trials…

Asia-PacificBiotechnologyPharmaceuticalPoliticsResearch

Broad welcome for UK budget proposals supporting bioscience sector and research

21-03-2013

UK Chancellor of the Exchequer George Osborne yesterday (March 20) presented his Budget Statement for…

BiotechnologyEuropeFinancialPharmaceuticalPoliticsResearch

Australian patients to benefit from Coalition PBS commitment; policies for Bio-Pharma

03-02-2013

The Australian Federal Coalition's election commitment to restoring transparency, certainty and confidence…

Asia-PacificBiotechnologyFinancialPharmaceuticalPoliticsResearch

UK's value-based pricing system plans lack clarity, MPs find

17-01-2013

The UK government's plans to overhaul the National Health Service pricing system for new drugs are poorly…

BiotechnologyEuropePharmaceuticalPoliticsPricingResearch

Partners in health care join to reverse decline in clinical research in UK

25-11-2012

The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA),…

BiotechnologyEuropePharmaceuticalPoliticsResearch

UK govt supports regenerative medicines, saying it is a priority area

11-11-2012

George Osborne, the UK's Chancellor of the Exchequer, spoke at the Royal Society last Friday of both…

BiotechnologyEuropeFinancialPharmaceuticalPoliticsRegulation

Canadian Senate committee finds faults in current clinical trials system

05-11-2012

The absence of a standardized approach to research ethics review significantly impacts the time required…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulationResearch

EMIG calls for greater clarity on value-based medicines from UK Parliamentary inquiry into NICE

31-10-2012

The UK Ethical Medicines Industry Group (EMIG) has welcomed the House of Commons Health Select Committee's…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

Confidential pricing agreements mitigate risks of low drug prices in key markets

18-10-2012

Pharmaceutical brand teams design their global launch sequencing strategies to mitigate the risks associated…

BiotechnologyGlobalPharmaceuticalPoliticsPricing

Australian govt details another review on patents

16-10-2012

The Australian government has announced the commission of an expert panel to review the "appropriateness…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

Time to consider longer patent terms, says Medicines Australia

15-10-2012

A new federal government review of Australia's patent system, announced yesterday, should consider the…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

EFPIA welcomes Commission policy strategy agenda to strengthen Pharma competitiveness

12-10-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the European Commission…

BiotechnologyEuropeMarkets & MarketingPatentsPharmaceuticalPoliticsPricing

Australian government proposes "tough new standards" for Innovation Patents

27-09-2012

Australia's federal government said in media release this week that it is "considering tough new standards…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

US House and Senate reconcile PDUFA reauthorization legislation

20-06-2012

The US Congress has released a reconciled Prescription Drug User Fee Act (PDUFA) reauthorization bill…

BiotechnologyLegalNorth AmericaPharmaceuticalPoliticsRegulation

German model for assessment of new medicines slammed by EU pharma leaders

11-06-2012

Leading pharmaceutical companies in Europe, represented in the European Federation of Pharmaceutical…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

UK pharma industry head fears for future of UK medical research

06-06-2012

The UK government is too focused on encouraging "breakthrough drugs" at the expense of significant gains…

BiotechnologyEuropePharmaceuticalPoliticsPricingResearch

1 to 25 of 35 results

Back to top